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Objective: To evaluate the antiulcer and analgesic effects of the aqueous root extract of
Lonchocarpus cyanescens (L. cyanescens) since the plant is said to have medicinal
properties.
Methods: The ﬁltrate of the aqueous root extract of the plant (100 mg/mL) was used to
evaluate for antiulcer activity in 20 rats divided into ﬁve groups of four rats each, which
were Groups A, B, and C that received 100, 200 and 300 mg/kg doses respectively, while
Group D was served as negative control and animals of Group E received 20 mg/kg dose
of ranitidine. Indomethacin at a dose of 15 mg/kg was used to induce ulcer on the day of
sacriﬁce. For acetic writhing test (antinociception), same design was used except that
Group E received 100 mg/kg dose of acetyl salicylic acid as standard drug. Abdominal
contractions were induced in the animals by intraperitoneal administration of 10 mL/kg of
0.6% of acetic acid.
Results: The aqueous root extract of L. cyanescens at all doses (100, 200 and 300 mg/
kg) showed signiﬁcant (P < 0.05) decrease in ulcer parameters compared with the
negative control. The extract also produced a signiﬁcant (P < 0.05) decrease in the
number of writhing reﬂexes in treated rats compared with negative control.
Conclusions: The aqueous root extract of L. cyanescens exhibited both antiulcer and
analgesic effects justifying folklore claim for the health beneﬁts of this plant.1. Introduction
Peptic ulcer, a gastrointestinal disorder, is usually acidic and
extremelypainful[1]. Peptic ulcers are small sores that form in the lining
oftheesophagus,stomachorduodenum[2].Pepticulcerdiseasecanlead
to serious complications including massive hemorrhage or bowel
perforation[3]. The pathophysiology of peptic ulcer has to do with an
imbalance between offensive factors such as acid, pepsin, or
Helicobacter pylori and defensive counterparts including mucin,
prostaglandin, bicarbonate, nitric oxide and growth factors[4]. It was
thought that this imbalance is as a result of the association of several
endogenous factors and aggressive exogenous factors leading to
constant confrontation in the stomach and upper small bowelbetween acid-pepsin aggression and mucosal defense. This imbal-
ance is also known to release leukotrienes and reactive oxygen spe-
cies[5]. It issaidthatfactorssuchasalcoholconsumption,useofsteroidal
and non-steroidal anti-inﬂammatory drugs, Helicobacter pylori in-
fections, improper digestion, smoking, metabolism, elimination of
food, mental and physical stressful lifestyle as well as drugs which
stimulate gastric acid and pepsin secretion could contribute to the
pathogenesis of gastritis[6]. Even though drugs are available for the
treatment of this condition, indications are that the high incidences of
side effects and drug interactions make these drugs of limited use.
These side effects culminate in the search for the development of
new antiulcer drugs in plants[7]. Medicinal plants have great
applications in the African region, hence there is heavy reliance on
these plants for alleviation of disease conditions in many rural areas
of Africa[8–10]. There is therefore the need to evaluate some of these
for efﬁcacy in line with folklore's claims. In this study, Lonchocarpus
cyanescens Benth (L. cyanescens) (Fabaceae) will be evaluated for
its antiulcer and analgesic properties.
L. cyanescens is a shrub or tree that grows in savannah for-
est[11,12]. The bark is implicated in the treatment of bone pains,
diabetes and the leaves and roots for treating boils and yaws[13].his is an open access article under the CC BY-NC-
Table 1
The criteria of ulcer score.
Criteria Ulcer score
No ulcer 0
Hemorrhagic and slight ulcer length less than 2 mm 1
Hemorrhagic and slight ulcer length less than 5 mm 2
More than 1 ulcer of grade 2 3
One ulcer less than 5 mm and diameter 2 mm 4
From 1 to 3 ulcers of grade 4 5
From 4 to 6 ulcers of grade 4 6
More than 6 ulcers of grade 4 7
Complete lesions with hemorrhage 8
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and anti-arthritic properties[14]. The leaves and roots of L.
cyanescens are applied as a poultice to treat skin diseases,
leprosy and ulcers but the roots are believed to be more
effective than the leaves in curative effect. The decoction from
the leaves and roots is also given to women during or after
childbirth and this decoction may also used as an aphrodisiac.
The decoction can also be used in the treatment of anti-arthritic
conditions, venereal diseases and diarrhea[14]. Phytochemically,
the leaves of L. cyanescens are rich in indoxyl which yields
indigotin contained in the indigo dyestuff. Oleanane derivatives
and glycyrrhetinic acid (GA) contained in this plant have anti-
inﬂammatory properties and are responsible for relief of peptic
ulcers observed in L. cyanescens[15]. The triterpenes act against
arthritis[14–16].
2. Materials and methods
2.1. Plant collection and extract preparation
Fresh roots of L. cyanescens were collected at the University
of Ibadan Campus and washed with water to remove the dirt. It
was then authenticated at the Department of Botany University
of Ibadan where a voucher specimen was deposited. About 20 g
of the plant was macerated using mortar and pestle and then
dissolved in 200 mL distilled water to make a 100 mg/mL
concentration. This was then ﬁltered using Whatman No. 1 ﬁlter
paper and the ﬁltrate collected was served as the aqueous extract
used in this study.
2.2. Animals
A total of 40 healthy male albino rats weighing between 100
and 200 g used in this study were procured and kept at the
Experimental Animal House, Department of Veterinary Physi-
ology, Biochemistry and Pharmacology, University of Ibadan
and kept in iron cages and fed with standard diet and clean water
ad libitum. All experimental procedures were conducted in
accordance to the University of Ibadan Ethics Committee on
Research in Animals. The study was conformed to internation-
ally accepted principles for the use and care of laboratory
animal[17].
2.3. Reagents and drugs
Drugs included indomethacin (Anthralon®, Ningbo Second
Pharma, China), ranitidine tablets (Aciloc 150®, Cadila Phar-
maceuticals, India) and acetylsalicylic and aspirin tablets (Bond
Chemicals Co., Ltd). Normal saline and distilled water were also
used.
2.4. The analgesic activity of L. cyanescens
A total of 20 male rats were randomly separated into ﬁve
groups of four animals each and they were treated as follows: in
Group I, rats were treated with the root extract of L. cyanescens
at a dose of 100 mg/kg. Rats of Groups II and III were treated
with 200 and 300 mg/kg root extract respectively. Rats of Group
IV were served as the negative control group and received
distilled water (2 mL/kg) while rats of Group V were served as
the positive control group and received acetylsalicylic acid at adose of 100 mg/kg. At 60 min after extract administration,
abdominal contractions were induced in the animals by intra-
peritoneal administration of 10 mL/kg of 0.6% of acetic acid[18].
The numbers of abdominal contractions over a period of 20 min
following the injection of acetic acid were recorded. The degree
of analgesia was calculated using the formula below:
Degree of analgesia =
Negative control −Treated group#
Negative control
× 100
where, * was number of abdominal contraction of negative
control and # was number of abdominal contraction of treated
group.
2.5. Antiulcer study of L. cyanescens
The experimental rats were randomly separated into ﬁve
groups of four rats each and were treated as follows: rats of
Groups A, B and C were treated with L. cyanescens leaves
extract at the dose of 100, 200 and 300 mg/kg respectively.
While rats of Group D were served as the negative control
group and received normal saline at a dose of 2 mL/kg, and
rats of Group E were served as the positive control group and
received ranitidine at 20 mg/kg. The plant extracts and drugs
were administered to the animals for 8 day. After 8-day
treatment, the animals were fasted for 24 h. Ulcer was
induced using indomethacin at a dose of 15 mg/kg on the day
of sacriﬁce. The animals were sacriﬁced at 6 h after indo-
methacin administration. After this the rats were eviscerated
and the stomachs were removed and cut open along the greater
curvature and washed in normal saline. Then it was laid ﬂat
and the number and degree of erosions were counted and
scored[19]. The criteria were used in the scoring of the ulcer
(Table 1).
2.5.1. Determination of preventive index
The preventive ulcer index was determined using the formula:
Preventive index=½ðUlcer index of negative control−Ulcer index of
treated groupÞ=Ulcer index of negative control ×100
2.6. Statistical analysis
The results obtained in this study were expressed as mean
± SEM. The statistical analysis was performed using ANOVA.
The student's t-test at 95% level of signiﬁcance was used to
assess signiﬁcant difference between control and treated
groups.
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The administration of the aqueous root extract of L. cya-
nescens in acetic writhing produced a signiﬁcant decrease (P <
0.05) in a number of writhing reﬂexes in treated rats at doses of
200 and 300 mg/kg only. While the dose of 200 mg/kg produced
18% decrease in writhing reﬂex and the dose of 300 mg/kg pro-
duced 43% decrease in writhing reﬂex indicating that dose-
dependent decreased. It is to be noted that at dose of 100 mg/
kg, there was no signiﬁcant decrease (P > 0.05) in writhing re-
ﬂexes in treated rats compared to negative control which indicated
that at this dose, the analgesic effect of the root extract produced
no effect (Table 2). In the case of the antiulcer activity, the
aqueous extract of L. cyanescens roots at all doses (100, 200 and
300 mg/kg) showed signiﬁcant (P < 0.05) decrease in ulcer pa-
rameters compared with the negative control. The dose of 200mg/
kg of the extract produced 80.7 preventive index being the highest
by the doses of the extract. This was followed by the dose of
100 mg/kg at 71 preventive index. Incidentally, the dose of
300 mg/kg of the extract was the least at 64.5 preventive index.
The result showed that there was dose related to the increase of
preventive index between doses of 100 and 200 mg/kg but the
decrease of preventive index at the dose of 300 mg/kg (Table 3).Table 2
Effect of aqueous root extract of L. cyanescens on the acetic acid-induced
abdominal contractions in rats (n = 4).
Groups Writhing reﬂex Pain inhibition (%)
I 52.8 ± 1.38* 0.00
II 43.0 ± 1.08* 17.78
III 29.8 ± 1.25* 43.02
IV (negative control) 52.3 ± 3.04* 0.00
V (positive control) 12.0 ± 0.71* 79.06
*: The values were signiﬁcant (P < 0.05). Rats of Group I were treated
with L. cyanescens root extract at a dose of 100 mg/kg. Rats of Group II
were treated with L. cyanescens root extract at a dose of 200 mg/kg. Rats
of Group III were treated with L. cyanescens root extract at a dose of
300 mg/kg. Rats of Group IV were negative control group and received
2 mL/kg distilled water. Rats of Group V were the positive control group
and received acetylsalicylic acid at a dose of 100 mg/kg.
Table 3
Effect of aqueous extract of L. cyanescens roots on indomethacin-induced
gastric ulcerations in rats.
Groups Ulcer score Preventive index
A 2.00 ± 0.42* 70.97
B 1.50 ± 0.50* 80.65
C 2.25 ± 0.48* 64.52
D (negative control) 7.75 ± 0.25* 0.00
E (positive control) 0.50 ± 0.29* 99.36
*: The values were signiﬁcant (P < 0.05). A: Rats treated with
L. cyanescens root extract at a dose of 100 mg/kg; B: Rats treated with
L. cyanescens root extract at a dose of 200 mg/kg; C: Rats treated with
L. cyanescens root extract at a dose of 300 mg/kg; D: Negative control
group rats received normal saline at a dose of 2 mL/kg; E: Positive
control group rats received ranitidine at 20 mg/kg.4. Discussion
The extract of whole roots of L. cyanescens showed signiﬁ-
cant antinociceptive effect in acetic acid-induced writhing
response. The writhe induced by acetic acid is a sensitive
method deployed in assessing the analgesic effect of medicinalplants[19]. From the observation, it was concluded that aqueous
extract of whole root of L. cyanescens at 200 mg/kg and
300 mg/kg body weight produced signiﬁcant analgesic activity
in albino rats while at the dose of 100 mg/kg, body weight did
not produce signiﬁcant difference as compared to control.
However, the effect of aspirin (100 mg/kg), the non-steroidal
anti-inﬂammatory drug used as positive control was greater
than that observed for the extract. The signiﬁcant analgesic ac-
tivity of L. cyanescens may be due to its content of GA, a tri-
terpenoid saponin which has been shown to possess anti-arthritic
and anti-inﬂammatory activities[19]. Oleanolic acid and ursolic
acid are triterpene saponins contained in the plant and may be
responsible for the analgesic activity of the plant[20]. Centella
asiatica whose major bioactive constituents are triterpene
saponins which have also been reported to have analgesic and
anti-inﬂammatory activity[21].
The antiulcer activity of the aqueous root extract of L. cya-
nescenswas evaluated in rats using the indomethacin-induced ulcer
model. A signiﬁcant antiulcer activity was observed for the extract
at all doses tested. Gastric mucosal damage caused by indometh-
acin and related non-steroidal anti-inﬂammatory drugs result from
the inhibition of prostaglandins synthesis via the arachidonic
pathway[21,22]. Thus, the effect of the extract in this model suggests
that it may possess cytoprotective action probably by enhancing
prostaglandins synthesis. L. cyanescens has been reported to
contain GA, a genin of glycyrrhizinic acid which has been used
extensively in the treatment of gastric ulcers[14,23]. GA is a
triterpenoid saponin and this chemical class which has also been
reported in licorice (Glycyrrhiza glabra) is known to offer
protection against ulcers[7,24].
Ranitidine hydrochloride, the standard drug used in this study
is a H2-receptor antagonist. Its use as antiulcer drug is due to its
ability to reduce acid secretion by blocking the histamine re-
ceptor type. Ranitidine is in the same class as cimetidine with the
only difference that it contains furan ring in place of imidazole
ring of cimetidine[25]. Any agents with anti-histaminic property
may thus have some form of antiulcer property.
The plant under study, L. cyanescens, is rich in GA which in-
hibits the enzymes (15-hydroxyprostaglandin dehydrogenase and
delta-13-prostaglandin) and that in turn metabolize the prosta-
glandins PGE-2a to their level of prostaglandins in the digestive
system. Prostaglandin is known to inhibit gastric secretion but
stimulate pancreatic secretion and mucous secretion in the in-
testines where it markedly increases the intestinal motility. GA, a
kindof triterpenoid,hasmanypharmacological effects suchasanti-
inﬂammatory, antiviral, antiulcer, and adrenal cortical hormone
kind function[7,14,26–29]. Clinical trials indicated that GA has a good
therapeutic effect on different types of dermatitis, purulent scar
disease, hair follicle infection and can as well as cure gingivitis,
esophagus inﬂammatory disease. GA is also known to have anti-
allergic, and anticancer activities[7]. GA has also been reported to
exhibit selective toxicity to varieties of tumor cells, which makes
it an ideal lead compound for anticancer treatment[30,31].
Histamine is released in inﬂammatory response and since GA has
anti-inﬂammatory effect, this property may have exhibited
through anti-histaminic effect hence its antiulcer effect may be
similar to thatof ranitidine[32].This studymayhave thus justiﬁed the
folkloric claim of this plant for analgesic and antiulcer activities.
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